Serological testing is a useful noninvasive method for the diagnosis of Helicobacter pylori infection. It is easy for patients to accept the test because of its noninvasiveness, and the results can be quickly obtained. Furthermore, this assay is a global test that evaluates the entire stomach. Therefore, potential sampling errors can be avoided.
Serological testing is a useful noninvasive method for the diagnosis of Helicobacter pylori infection. It is easy for patients to accept the test because of its noninvasiveness, and the results can be quickly obtained. Furthermore, this assay is a global test that evaluates the entire stomach. Therefore, potential sampling errors can be avoided. 1 Many serological kits for H. pylori detection are commercially available in clinical practice. The sensitivity of enzyme-linked immunosorbent assay (ELISA)-based serological tests ranges between 90% and 97%, and the specificity ranges between 50% and 96%. [2] [3] [4] The sensitivity and specificity of serological tests mainly depend on the nature of the antigenic materials used. In addition to the antigens used, the presence of atrophic gastritis is also one of the important factors that influence the test's accuracy.
In 10 who recently evaluated the validity of biopsy-based tests (histology, culture, and urease test) and serological tests for detection of H. pylori infection, also reported a decreased specificity of serological tests for the diagnosis of H. pylori infection in patients with atrophic gastritis. When their analysis was limited to patients without atrophic gastritis or intestinal metaplasia, all tests, except for culture, showed sensitivity and specificity > 90%. However, the sensitivity of the CLO test markedly decreased with the progression of atrophic gastritis and intestinal metaplasia, and the serological test was markedly less specific in the presence of atrophic gastritis (specificity, 40.7% vs. 83.7% in patients with and without atrophic gastritis, respectively). The authors suggested that a combination of at least 2 tests is necessary for the detection of H. pylori in the clinical settings of atrophic gastritis or intestinal metaplasia.
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Hung et al 5 reported that the results of ELISA were indeterminate in 12.4% (21/170) of their patients. They excluded these cases in the final analysis, but such high uncertainty will influence the application of serological tests as diagnostic or screening tools. A "gray zone" result is a significant limitation of serological tests. H. pylori infection induces mucosal inflammation in the stomach. Infected patients have shown a wide variety of systemic antibody responses, thereby leading to several indeterminate results in serological tests. 1 In cases with indeterminate results, other tests should be performed to determine the status of H. pylori infection.
In addition, the accuracy of serological tests might vary between different races and geographic regions, possibly due to different antigenic properties of local bacterial strains and antibodies of commercial kits used for the diagnosis of H. pylori infection. The usefulness of a serological assay should be assessed in a local setting.
In conclusion, the sensitivity of biopsy-based tests for the diagnosis of H. pylori infection decreases with the progression of atrophic gastritis. Quantitative ELISA is a noninvasive and sensitive test for detection of H. pylori infection in subjects with atrophic gastritis, but this test is less specific in the presence of atrophic gastritis. A combination of at least 2 tests (e.g. serology plus urea breath test) is necessary in clinical practice to diagnose H. pylori infection accurately in patients with atrophic gastritis or intestinal metaplasia. If discordant results of the tests exist, another sensitive test (e.g. histology) can be performed to determine the status of H. pylori.
